A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.

Wattanakul, Thanaporn; Chotsiri, Palang; Scandale, Ivan; Hoglund, Richard M; Tarning, Joel

Wattanakul, Thanaporn; Chotsiri, Palang; Scandale, Ivan; Hoglund, Richard M; Tarning, Joel.

Afiliación

Wattanakul T; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Chotsiri P; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Scandale I; Drugs for Neglected Diseases Initiative, Geneva, Switzerland.
Hoglund RM; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Tarning J; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Expert Rev Clin Pharmacol ; 15(8): 945-958, 2022 Aug.

Article en En | MEDLINE | ID: mdl-36017624

Asunto(s)

Tratamiento Farmacológico de COVID-19; Antivirales/uso terapéutico; Reposicionamiento de Medicamentos/métodos; Humanos; Pandemias; Estudios Prospectivos; SARS-CoV-2

Palabras clave

COVID-19; Drug repurposing; SARS-CoV-2; pharmacometrics; population pharmacokinetics; simulations

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Expert Rev Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Tailandia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google